Royal Bank Of Canada Agios Pharmaceuticals, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 34,343 shares of AGIO stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,343
Previous 38,142
9.96%
Holding current value
$1.07 Million
Previous $1.69 Million
33.41%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AGIO
# of Institutions
244Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$176 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$175 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$151 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$109 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$75.3 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.7B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...